Genetic Polymorphism of CYP2C19 and Inhibitory Effects of Ticagrelor and Clopidogrel Towards Post-Percutaneous Coronary Intervention (PCI) Platelet Aggregation in Patients with Acute Coronary Syndromes

BACKGROUND: The aim of this study was to observe the effects of genetic polymorphism of CYP2C19 on inhibitory effects of ticagrelor (Tic) and clopidogrel (Clo) towards post-percutaneous coronary intervention (PCI) platelet aggregation (IPA) and major cardiovascular events (MACE) in patients with acu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Peng, Yang, Xinchun, Bian, Suyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Scientific Literature, Inc. 2016
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181574/
https://www.ncbi.nlm.nih.gov/pubmed/27977637
http://dx.doi.org/10.12659/MSM.902120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5181574/
https://www.ncbi.nlm.nih.gov/pubmed/27977637
http://dx.doi.org/10.12659/MSM.902120

Ejemplares similares